Connecting Science to Psoriatic Arthritis Patient Care

Connecting Science to Psoriatic Arthritis Patient Care

Host: Matt Birnholz, MD Guest: Philip Mease, MD Guest: Allan Gibofsky, MD, JD, MACR, FACP, FCLM Science is moving forward in understanding the key inflammatory pathways involved in psoriasis and psoriatic arthritis, which has led to the development of targeted, effective therapies for patients with these diseases. But with these advances, it’s becoming more and more important for clinicians to understand how to choose treatment options appropriately and how to discuss them with patients. To explore the use of available treatments for psoriatic arthritis, Dr. Matt Birnholz sits down with Dr. Philip Mease and Dr. Allan Gibofsky.

Connecting Science to Psoriatic Arthritis Patient Care

Host: Matt Birnholz, MD Guest: Philip Mease, MD Guest: Allan Gibofsky, MD, JD, MACR, FACP, FCLM Science is moving forward in understanding the key inflammatory pathways involved in psoriasis and psoriatic arthritis, which has led to the development of targeted, effective therapies for patients with these diseases. But with these advances, it’s becoming more and more important for clinicians to understand how to choose treatment options appropriately and how to discuss them with patients. To explore the use of available treatments for psoriatic arthritis, Dr. Matt Birnholz sits down with Dr. Philip Mease and Dr. Allan Gibofsky.

Connecting Science to Psoriatic Arthritis Patient Care

Host: Matt Birnholz, MD Guest: Philip Mease, MD Guest: Allan Gibofsky, MD, JD, MACR, FACP, FCLM Science is moving forward in understanding the key inflammatory pathways involved in psoriasis and psoriatic arthritis, which has led to the development of targeted, effective therapies for patients with these diseases. But with these advances, it’s becoming more and more important for clinicians to understand how to choose treatment options appropriately and how to discuss them with patients. To explore the use of available treatments for psoriatic arthritis, Dr. Matt Birnholz sits down with Dr. Philip Mease and Dr. Allan Gibofsky.

IL-6 and the Molecular Origins of RA Inflammation

Guest: Alan Epstein, MD Overproduction of the cytokine interleukin 6 (IL-6) has been implicated in the pathogenesis of rheumatoid arthritis and is a critical driver of the inflammatory and destructive aspects of the disease. Dr. Alan Epstein, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine, talks about IL-6’s pivotal role in the development of RA. Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

IL-6 and the Molecular Origins of RA Inflammation

Guest: Alan Epstein, MD Overproduction of the cytokine interleukin 6 (IL-6) has been implicated in the pathogenesis of rheumatoid arthritis and is a critical driver of the inflammatory and destructive aspects of the disease. Dr. Alan Epstein, Clinical Professor of Medicine at the University of Pennsylvania School of Medicine, talks about IL-6’s pivotal role in the development of RA. https://www.reachmd.com/admin/radio/segment/9797/ReachMD.com/addressingRA is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD . This series is intended for healthcare professionals only.